Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment.
Oncol Lett. 2023 Oct 23;26(6):523. doi: 10.3892/ol.2023.14110. eCollection 2023 Dec.
Oncol Lett. 2023.
PMID: 37927419
Free PMC article.
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.
Akyildiz A, Guven DC, Ozluk AA, Ismayilov R, Mutlu E, Unal OU, Yildiz I, Iriagac Y, Turhal S, Akbas S, Bayram E, Telli TA, Turkoz FP, Ozcelik M, Erciyestepe M, Selvi O, Gulbagci B, Erturk I, Isleyen ZS, Kahraman S, Akdag MO, Hamitoglu B, Unek IT, Unal C, Hacibekiroglu İ, Arslan C, Azizy A, Helvaci K, Demirci U, Dizdar O, Basaran M, Goker E, Sendur MA, Yalcin S.
Akyildiz A, et al. Among authors: hamitoglu b.
Medicine (Baltimore). 2023 Nov 10;102(45):e35950. doi: 10.1097/MD.0000000000035950.
Medicine (Baltimore). 2023.
PMID: 37960746
Free PMC article.
Item in Clipboard
Cite
Cite